Skip to Main Content

Author Details

Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
1993
36
24
PMIDPaper TitleJournal TitlePublished Year
35123819Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.Eur Urol2022
33504940Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.Prostate Cancer Prostatic Dis2021
32253928An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer.J Endourol2020
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29960750A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.Eur Urol2018
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
26951947Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.Eur Urol2016
25749786Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters.Eur Radiol2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
23065704A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Hum Mol Genet2013
23774040A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.Contemp Clin Trials2013
23535732Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Nat Genet2013
21743467Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.Nat Genet2011
19040532Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.BJU Int2009
27628454Port site hernias following robot-assisted laparoscopic prostatectomy.J Robot Surg2009
19767753Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.Nat Genet2009
19767752Multiple loci on 8q24 associated with prostate cancer susceptibility.Nat Genet2009
19513068High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series.Br J Cancer2009
19050691Identification of new genetic risk factors for prostate cancer.Asian J Androl2009
18165275Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.J Mol Diagn2008
18264097Multiple newly identified loci associated with prostate cancer susceptibility.Nat Genet2008
17125476Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapy.BJU Int2006
17520650Robotic prostatectomy: the first UK experience.Int J Med Robot2006
15610124Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer?BJU Int2004
11680707Exclusive amplification of cDNA template (EXACT) RT-PCR to avoid amplifying contaminating genomic pseudogenes.Biotechniques2001
11371938Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.J Urol2001
10848690Morbidity and the impact on daily activities associated with catheter drainage after acute urinary retention.BJU Int2000
12497162Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer.Prostate Cancer Prostatic Dis2000
10368252The expression of PAX5 in human transitional cell carcinoma of the bladder: relationship with de-differentiation.BJU Int1999
9806178Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes.Br J Urol1998
9158510Multiple frequent recurrences in superficial transitional cell carcinoma of the bladder: is survival compromised by a conservative management strategy?Br J Urol1997
8800890A 12-month study of the placebo effect in transurethral microwave thermotherapy.Br J Urol1996
7536261The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study.J Urol1995
7678047Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction.Lancet1993
7683985Clinical response to transurethral microwave thermotherapy is thermal dose dependent.Eur Urol1993
  • 1 - 36 of 36

Recommended Authors

University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 8
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 17
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 25
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 2
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 3
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 8
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 6
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 5
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 4
University of Toronto
Career Start Year 1989
Number of shared co-authors 43
Monash University
Career Start Year 1988
Number of shared co-authors 11
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 3
University of California Davis
Career Start Year 1988
Number of shared co-authors 13
University of Melbourne
Career Start Year 1988
Number of shared co-authors 7
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 16
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 2
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 7
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 41
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 2
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 4
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 7
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 12
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 6
Rutgers Cancer Institute of New Jersey
Career Start Year 1975
Number of shared co-authors 3
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 13
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 17
University of Toronto, University Health Network
Career Start Year 1971
Number of shared co-authors 4
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 3
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 36

Collaborators

The Royal Marsden NHS Foundation Trust
Co-authored papers 13
Norwich Medical School, University of East Anglia
Co-authored papers 13
The Institute of Cancer Research
Co-authored papers 13
The Institute of Cancer Research
Co-authored papers 13
University of Oxford, John Radcliffe Hospital
Co-authored papers 11
Royal Marsden NHS Foundation Trust
Co-authored papers 11
University Hospital Southampton NHS Foundation Trust
Co-authored papers 11
University of Cambridge
Co-authored papers 10
Oncogenetics Team The Institute of Cancer Research London UK.
Co-authored papers 10
University of Oxford
Co-authored papers 9
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 9
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 8
The Institute of Cancer Research
Co-authored papers 8
Co-authored papers 7
Co-authored papers 6
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 6
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Co-authored papers 5
Norwich Medical School, University of East Anglia
Co-authored papers 5
The Institute of Cancer Research
Co-authored papers 5
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 5
Imperial Clinical Analytics
Co-authored papers 5
Royal Marsden NHS Foundation Trust
Co-authored papers 5
Fred Hutchinson Cancer Research Center
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Wellcome Sanger Institute
Co-authored papers 4
University College London
Co-authored papers 4
Co-authored papers 4
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 4
University College London
Co-authored papers 4
University College London
Co-authored papers 4